Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in VKTX — Viking Therapeutics, Inc.

CIK 923093 STAMFORD, CT

Position in VKTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,697,882
+$5,394,408 QoQ
Shares Held
197,331
+178.8% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#60
of 435 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Jun 30, 2026
CallValue
$3,510,900
CallShares
90,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $414,135,114 across 107 Biotechnology names. VKTX ranks #12 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VKTX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,510,900 90,000
2026-06-30 $7,697,882 197,331
2026-03-31 $2,303,474 70,789
2026-03-31 $231,034 7,100
2025-12-31 $3,053,624 86,800
2025-12-31 $1,710,064 48,609
2025-12-31 $858,392 24,400
2025-09-30 $336,384 12,800
2025-09-30 $2,218,032 84,400
2025-06-30 $212,000 8,000
2025-03-31 $4,156,794 172,124
2024-06-30 $561,906 10,600
2024-06-30 $249,147 4,700
2024-03-31 $2,107,400 25,700
2024-03-31 $803,600 9,800
2023-06-30 $673,428 41,544
2023-03-31 $464,401 27,892
2022-12-31 $139,984 14,892